Inventor · disambiguated record
Susan Kingsman
Also filed as: KINGSMAN SUSAN · KINGSMAN SUSAN A · KINGSMAN SUSAN M · KINGSMAN SUSAN MARY
35 granted patents·34 pending applications·1,055 citations·filing 1982–2012
98Inventor score
Top patents by PatentIndex Score
69 records- 0197US7303910B2Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 2004·Granted Dec 4, 2007·137 cites·6 claims
- 0297US7056699B2Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2005·Granted Jun 6, 2006·46 cites·9 claims
- 0397US6924123B2Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2002·Granted Aug 2, 2005·64 cites·6 claims
- 0497US4615974AYeast expression vectorsCELLTECH LTD·Filed 1982·Granted Oct 7, 1986·125 cites·11 claims
- 0593US7514546B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2006·Granted Apr 7, 2009·13 cites·25 claims
- 0693US7198784B2Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 2003·Granted Apr 3, 2007·43 cites·19 claims
- 0793US6312682B1Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 1998·Granted Nov 6, 2001·115 cites·71 claims
- 0893US4918166AParticulate hybrid HIV antigensOXFORD GENE SYSTEMS·Filed 1987·Granted Apr 17, 1990·110 cites·3 claims
- 0991US7074909B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2001·Granted Jul 11, 2006·27 cites·13 claims
- 1089US8084249B2VectorKINGSMAN SUSAN MARY·Filed 2010·Granted Dec 27, 2011·9 cites·6 claims
- 1189US6669936B2Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 2001·Granted Dec 30, 2003·34 cites·75 claims
- 1286US7531648B2Vector encoding an antibody that binds 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2002·Granted May 12, 2009·8 cites·13 claims
- 1386US6800281B2Lentiviral-mediated growth factor gene therapy for neurodegenerative diseasesOXFORD BIOMEDICA LTD·Filed 2001·Granted Oct 5, 2004·17 cites·15 claims
- 1484US7718627B2VectorOXFORD BIOMEDICA LTD·Filed 2006·Granted May 18, 2010·4 cites·24 claims
- 1584US6852703B1Tumor targeted vectorOXFORD BIOMEDICA LTD·Filed 1998·Granted Feb 8, 2005·39 cites·31 claims
- 1682US7910109B2MHC class II epitopes of 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2003·Granted Mar 22, 2011·8 cites·5 claims
- 1781US6096538ARetroviral vectorsOXFORD BIOMEDICA LTD·Filed 1996·Granted Aug 1, 2000·52 cites·36 claims
- 1877US6235522B1Lentiviral vectorsOXFORD BIOMEDICA LTD·Filed 1997·Granted May 22, 2001·40 cites·15 claims
- 1976US7888115B2MHC class I peptide epitopes from the human 5T4 tumor-associated antigenOXFORD BIOMEDICA LTD·Filed 2009·Granted Feb 15, 2011·1 cites·2 claims
- 2075US7541044B2Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigensOXFORD BIOMEDICA LTD·Filed 2006·Granted Jun 2, 2009·2 cites·16 claims
- 2175US7276488B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Oct 2, 2007·2 cites·18 claims
- 2274US5739007AHybrid GAL10/pgk yeast promoterDELTA BIOTECHNOLOGY LTD·Filed 1993·Granted Apr 14, 1998·44 cites·13 claims
- 2373US2010040539A1Vector SystemOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 2471US7635687B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Dec 22, 2009·2 cites·7 claims
- 2569US2009017532A1VectorOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 2667US7575916B2Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid moleculeOXFORD BIOMEDICA LTD·Filed 2003·Granted Aug 18, 2009·3 cites·2 claims
- 2767US6818209B1Retroviral delivery systemOXFORD BIOMEDICA LTD·Filed 1999·Granted Nov 16, 2004·21 cites·21 claims
- 2867US2005032216A1VectorOXFORD BIOMEDICA LTD·Filed 2004·Application pending·0 cites
- 2966US6808922B1Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 1998·Granted Oct 26, 2004·14 cites·41 claims
- 3064US6168916B1Host adaptation of retroviral vectorsOXFORD BIOMEDICA LTD·Filed 1996·Granted Jan 2, 2001·23 cites·20 claims
- 3164US2008064106A1Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2007·Application pending·0 cites
- 3264US2009291491A1Retroviral vectorsKINGSMAN ALAN JOHN·Filed 2008·Application pending·0 cites
- 3362US2008125387A1AnemiaBINLEY KATIE MARY·Filed 2007·Application pending·0 cites
- 3461US5041385AVector expressing fusion proteins and particlesOXFORD GENE SYSTEMS·Filed 1987·Granted Aug 20, 1991·14 cites·2 claims
- 3561US2006177934A1Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2006·Application pending·0 cites
- 3660US5008373AFusion proteins and particlesOXFORD GENE SYSTEMS·Filed 1987·Granted Apr 16, 1991·14 cites·5 claims
- 3760US2011052577A1AntibodiesOXFORD BIOMEDICA LTD·Filed 2010·Application pending·0 cites
- 3859US2007104690A1Retroviral vectorsKINGSMAN ALAN J·Filed 2006·Application pending·0 cites
- 3958US2009111106A1Vector SystemMITROPHANOUS KYRI·Filed 2008·Application pending·0 cites
- 4057US2008175819A1Vector systemOXFORD BIOMEDICA LTD·Filed 2007·Application pending·0 cites
- 4157US2006099180A1Retroviral delivery systemMITROPHANOUS KYRIACOS A·Filed 2004·Application pending·0 cites
- 4256US2004202642A1Lentiviral-mediated growth factor gene therapy for nerodegenerative diseasesFiled 2004·Application pending·0 cites
- 4356US2005124564A1AnemiaFiled 2004·Application pending·0 cites
- 4455US6541219B1Therapeutic GeneFiled 1997·Granted Apr 1, 2003·9 cites·11 claims
- 4554US2004076613A1Vector systemFiled 2003·Application pending·0 cites
- 4653US2007161080A1AntibodiesOXFORD BIOMEDICA LTD·Filed 2006·Application pending·0 cites
- 4753US2009191230A1CascadeOXFORD BIOMEDICA LTD·Filed 2006·Application pending·0 cites
- 4852US2004170608A1Use of a lentiviral vector in the treatment of painFiled 2004·Application pending·0 cites
- 4951US8133681B2Chemo-immunotherapy methodHARROP RICHARD·Filed 2008·Granted Mar 13, 2012·0 cites·5 claims
- 5051US2008131400A1Vector systemMAZARAKIS NICHOLAS·Filed 2007·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Susan Kingsman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →